- Home
- FOXF vs LMAT Comparison
FOXF vs LMAT Comparison
Compare FOXF & LMAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FOXF
- LMAT
- Stock Information
- Founded
- FOXF 2007
- LMAT 1983
- Country
- FOXF United States
- LMAT United States
- Employees
- FOXF N/A
- LMAT N/A
- Industry
- FOXF Motor Vehicles
- LMAT Medical/Dental Instruments
- Sector
- FOXF Consumer Discretionary
- LMAT Health Care
- Exchange
- FOXF Nasdaq
- LMAT Nasdaq
- Market Cap
- FOXF N/A
- LMAT 1.9B
- IPO Year
- FOXF N/A
- LMAT 2006
- Fundamental
- Price
- FOXF $28.53
- LMAT $83.85
- Analyst Decision
- FOXF Buy
- LMAT Buy
- Analyst Count
- FOXF 7
- LMAT 6
- Target Price
- FOXF $36.43
- LMAT $100.80
- AVG Volume (30 Days)
- FOXF 523.3K
- LMAT 150.8K
- Earning Date
- FOXF 07-31-2025
- LMAT 07-31-2025
- Dividend Yield
- FOXF N/A
- LMAT 0.96%
- EPS Growth
- FOXF N/A
- LMAT 30.45
- EPS
- FOXF N/A
- LMAT 1.97
- Revenue
- FOXF $1,415,479,000.00
- LMAT $226,256,000.00
- Revenue This Year
- FOXF $5.17
- LMAT $13.88
- Revenue Next Year
- FOXF $6.34
- LMAT $8.81
- P/E Ratio
- FOXF N/A
- LMAT $42.49
- Revenue Growth
- FOXF 1.26
- LMAT 13.19
- 52 Week Low
- FOXF $17.95
- LMAT $71.42
- 52 Week High
- FOXF $54.86
- LMAT $109.58
- Technical
- Relative Strength Index (RSI)
- FOXF 69.52
- LMAT 53.42
- Support Level
- FOXF $24.42
- LMAT $80.86
- Resistance Level
- FOXF $25.22
- LMAT $84.98
- Average True Range (ATR)
- FOXF 1.02
- LMAT 2.16
- MACD
- FOXF 0.18
- LMAT 0.20
- Stochastic Oscillator
- FOXF 96.22
- LMAT 71.12
About LMAT LeMaitre Vascular Inc.
LeMaitre Vascular Inc manufactures and distributes medical devices for the treatment of peripheral vascular disease. Its products are used during open vascular surgery and address several anatomical areas, such as the carotid, lower extremities, upper extremities, and aorta. The firm's lower extremities product line contributes towards the proportion of revenue, followed by the carotid product line. LeMaitre's surgical devices include angioscopes, balloon catheters, carotid shunts, phlebectomy devices, vascular grafts, vascular patches, and vessel closure systems. LeMaitre generates the majority of its revenue in the United States.